CELL-MEDIATED IMMUNE-RESPONSES AFTER IMMUNIZATION OF HEALTHY SERONEGATIVE CHILDREN WITH VARICELLA VACCINE - KINETICS AND SPECIFICITY

被引:50
作者
WATSON, B
KELLER, PM
ELLIS, RW
STARR, SE
机构
[1] CHILDRENS HOSP PHILADELPHIA,JOSEPH STOKES JR RES INST,DIV INFECT DIS & IMMUNOL,PHILADELPHIA,PA 19104
[2] MERCK SHARP & DOHME LTD,DEPT CELLULAR & MOLEC BIOL,W POINT,PA 19486
关键词
D O I
10.1093/infdis/162.4.794
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Humoral and cell-mediated immune responses were determined in seronegative children immunized with live attenuated Oka strain varicella vaccine. At 2 weeks after immunization, 80% of children had detectable lymphocyte proliferation to varicella-zoster virus (VZV) antigens, while only 4% had antibodies to VZV as detected by ELISA. By 6 weeks after immunization, 97% of children seroconverted, and 95% of these responded to VZV antigens in the proliferation assay. A high proportion of immunized children also responded in the proliferation assay to purified glycoproteins I, II, and III of VZV. These results indicate that most children develop a broad cell-mediated immune response to VZV antigens within weeks after immunization with varicella vaccine. © 1990, by The University of Chicago.
引用
收藏
页码:794 / 799
页数:6
相关论文
共 13 条
  • [1] ARBETER AM, 1983, PEDIATRICS, V71, P307
  • [2] ARBETER AM, 1986, PEDIATRICS, V78, P748
  • [3] LIVE ATTENUATED VARICELLA VACCINE - IMMUNIZATION OF HEALTHY-CHILDREN WITH THE OKA STRAIN
    ARBETER, AM
    STARR, SE
    WEIBEL, RE
    PLOTKIN, SA
    [J]. JOURNAL OF PEDIATRICS, 1982, 100 (06) : 886 - 893
  • [4] ARVIN AM, 1986, J IMMUNOL, V137, P1346
  • [5] EARLY IMMUNE-RESPONSE IN HEALTHY AND IMMUNOCOMPROMISED SUBJECTS WITH PRIMARY VARICELLA-ZOSTER VIRUS-INFECTION
    ARVIN, AM
    KOROPCHAK, CM
    WILLIAMS, BRG
    GRUMET, FC
    FOUNG, SKH
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (03) : 422 - 429
  • [6] NEW COMMON NOMENCLATURE FOR GLYCOPROTEIN GENES OF VARICELLA-ZOSTER VIRUS AND THEIR GLYCOSYLATED PRODUCTS
    DAVISON, AJ
    EDSON, CM
    ELLIS, RW
    FORGHANI, B
    GILDEN, D
    GROSE, C
    KELLER, PM
    VAFAI, A
    WROBLEWSKA, Z
    YAMANISHI, K
    [J]. JOURNAL OF VIROLOGY, 1986, 57 (03) : 1195 - 1197
  • [7] IMMUNITY TO WHOLE VARICELLA-ZOSTER VIRUS-ANTIGEN AND GLYCOPROTEIN-I AND GLYCOPROTEIN-P170 - RELATION TO THE IMMUNIZING REGIMEN OF LIVE ATTENUATED VARICELLA VACCINE
    DIAZ, PS
    SMITH, S
    HUNTER, E
    ARVIN, AM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (06) : 1245 - 1252
  • [8] CELLULAR AND HUMORAL IMMUNITY TO VARICELLA ZOSTER VIRUS GLYCOPROTEINS IN IMMUNE AND SUSCEPTIBLE HUMAN-SUBJECTS
    GILLER, RH
    WINISTORFER, S
    GROSE, C
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (06) : 919 - 928
  • [9] PURIFICATION OF INDIVIDUAL VARICELLA-ZOSTER VIRUS (VZV) GLYCOPROTEIN-GPI, GLYCOPROTEIN-GPII, AND GLYCOPROTEIN-GPIII AND THEIR USE IN ELISA FOR DETECTION OF VZV GLYCOPROTEIN-SPECIFIC ANTIBODIES
    KELLER, PM
    LONERGAN, K
    NEFF, BJ
    MORTON, DA
    ELLIS, RW
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1986, 14 (02) : 177 - 188
  • [10] KUMAGAI T, 1980, Journal of Infectious Diseases, V141, P7, DOI 10.1093/infdis/141.1.7